331 related articles for article (PubMed ID: 32717489)
1. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.
Heesom L; Rehnberg L; Nasim-Mohi M; Jackson AIR; Celinski M; Dushianthan A; Cook P; Rivinberg W; Saeed K
J Glob Antimicrob Resist; 2020 Sep; 22():782-784. PubMed ID: 32717489
[No Abstract] [Full Text] [Related]
2. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
Lippi G; Plebani M
Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
[No Abstract] [Full Text] [Related]
3. The Role of Chest Radiograph, Procalcitonin and Moxifloxacin in Diagnosis and Management of Breast Cancer Patients with COVID-19.
Rinaldi I; Muthalib A; Astowo P; Irawan B; Susanto N; Magdalena L; Maha IHRT; Wicaksono S
Acta Med Indones; 2020 Apr; 52(2):163-171. PubMed ID: 32778631
[TBL] [Abstract][Full Text] [Related]
4. Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.
Davis MW; McManus D; Koff A; Jaszczur GR; Malinis M; Dela Cruz C; Britto CJ; Price C; Azmy V; Kaman K; Gaston D; Early K; DeWitt M; Song JS; Ortiz C; Juthani-Mehta M; Topal JE
Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1335-1337. PubMed ID: 32507113
[TBL] [Abstract][Full Text] [Related]
5. Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients?
Krupp K; Madhivanan P; Perez-Velez CM
J Infect; 2020 Sep; 81(3):452-482. PubMed ID: 32562790
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
van Berkel M; Kox M; Frenzel T; Pickkers P; Schouten J;
Crit Care; 2020 Oct; 24(1):600. PubMed ID: 33023606
[No Abstract] [Full Text] [Related]
7. What to Expect from Antibody Assays of SARS-CoV-2?
Yi X; Cao J
J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
[No Abstract] [Full Text] [Related]
8. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?
Côrtes MF; de Almeida BL; Espinoza EPS; Campos AF; do Nascimento Moura ML; Salomão MC; Boszczowski I; Freire MP; de Carvalho LB; Paranhos-Baccalà G; Costa SF; Guimarães T
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115344. PubMed ID: 34243136
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 outbreak.
Patrucco F; Gavelli F; Shi R; De Vita N; Pavot A; Castello LM; Ravanini P; Balbo PE
Panminerva Med; 2020 Jun; 62(2):73-74. PubMed ID: 32208412
[No Abstract] [Full Text] [Related]
11. Re-emergence of SARS-CoV2 in a discharged COVID-19 case.
Zhou M; Li Q; Cao L; Liu Y; Zha Y; Xie H; Zeng M; Shi X; Gao Y; Xie L; Luo M; Zeng Y
J Microbiol Immunol Infect; 2020 Jun; 53(3):501-502. PubMed ID: 32303482
[No Abstract] [Full Text] [Related]
12. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
[TBL] [Abstract][Full Text] [Related]
13. High-resolution computed tomography in a patient with COVID-19 with non-diagnostic serial radiographs.
Kwok HM; Wong SC; Ng TF; Yung KS; Luk WH; Ma KF; Chik TSH
Hong Kong Med J; 2020 Jun; 26(3):248.e1-249.e3. PubMed ID: 32362588
[No Abstract] [Full Text] [Related]
14. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
Greene DN
J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2.
Decru B; Van Elslande J; Weemaes M; Houben E; Empsen I; André E; Van Ranst M; Lagrou K; Vermeersch P
Clin Chem Lab Med; 2020 Sep; 58(10):e197-e199. PubMed ID: 32628628
[No Abstract] [Full Text] [Related]
16. Dynamic relationship between D-dimer and COVID-19 severity.
Li Y; Zhao K; Wei H; Chen W; Wang W; Jia L; Liu Q; Zhang J; Shan T; Peng Z; Liu Y; Yan X
Br J Haematol; 2020 Jul; 190(1):e24-e27. PubMed ID: 32420615
[No Abstract] [Full Text] [Related]
17. Could the COVID-19 pandemic aggravate antimicrobial resistance?
Rossato L; Negrão FJ; Simionatto S
Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
[No Abstract] [Full Text] [Related]
18. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
[No Abstract] [Full Text] [Related]
19. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
[No Abstract] [Full Text] [Related]
20. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
